Israeli team develops 'anti-diabetes drug'
463 million people have been diagnosed with diabetes worldwide
and up to 95% of this number have Type 2.
top of page
Hi, thanks for stopping by!
Concenter BioPharma is a subsidiary of Silkim Pharma Ltd., which developed a novel, protected PLATFORM of drugs for proven treatments of multiple indications.
Our PLATFORM is the result of extensive investigation of animal models of human diseases.
Let the news
come to you.
bottom of page
Comments